NCT06986993 - Impact of Semaglutide on Tobacco Use and Related Health Behaviors | Biotech Hunter

Enrollment

40

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

May 30, 2028

Study Completion Date

June 30, 2028

Conditions

Tobacco Use

Interventions

DRUG

Semaglutide

Participants are randomized to receive either semaglutide or placebo (saline) via sc injection once a week for 12 weeks. Dose will be titrated per recommendations every 4 weeks,starting at .25mg, then 0.5mg and then 1.0mg

DRUG

Placebo

Participants are randomized to receive either semaglutide or placebo (saline) via sc injection once a week for 12 weeks. Dose will be titrated per recommendations every 4 weeks,starting at .25mg, then 0.5mg and then 1.0mg

Trial Locations (1)

73104

RECRUITING

Health Promotion Research Center, Oklahoma City